Medical and Scientific: Breast cancer breakthrough

26 Feb 2021 - Medical and Scientific

Breast cancer patients given a common beta-blocker at the time of diagnosis are almost twice as likely to be alive five years later. The findings from a retrospective study of 4000 women add to growing evidence a medication typically given to reduce high blood pressure or prevent heart damage during chemotherapy could be given at the time of diagnosis to stop cancer spreading. Erica Sloan, lead researcher from the Monash Institute of Pharmaceutical Sciences, said they offered a promising new way to address the stress of a cancer diagnosis. “Stress does have a biological effect on the body and stress is part of a cancer diagnosis”. Beta-blockers protect the heart by reducing the effects of stress hormones, such as adrenaline.

West Australian; 26/02/2021; Page 16; Courier Mail Brisbane; 26/02/2021; Page 8